Home Discover Journals Examining the latest developments in diabetes treatments

Examining the latest developments in diabetes treatments

By Finserv MARKETS - Dec 5,2019
Views Icon137 Views 0 0 Comments

Developments in Diabetes Treatment

Statistics show that the prevalence of diabetes is increasing in India with each passing year. By 2030, the number of Indians suffering from this condition could go up to 98 million. This trend is likely to manifest globally too. Each year, November 14th marks the observation of World Diabetes Day, which aims to increase awareness about the effects of diabetes and the complications caused by the condition.

Having diabetes can increase your risk of developing other health problems, such as heart disease and stroke. In the long run, that could mean escalating medical costs. To better tackle the financial implications of this condition, it’s a smart move to invest in a health insurance policy.

On Finserv MARKETS, you can opt for a comprehensive health insurance policy that not only offers protective cover for yourself, but also helps insure your family’s health. Investing in a health cover on Finserv MARKETS can help you hedge your finances against rising health costs, tackle unexpected medical emergencies, and also enjoy health insurance tax benefits in the process. What’s even better is that with health insurance policies available on Finserv MARKETS, you can enjoy extensive coverage across 6500+ empaneled hospitals in India.

Developments in Diabetes Treatment

Source: livemint.com

The rising incidence of diabetes among Indians is certainly grim news. However, it appears that there’s a silver lining in sight. Dedicated and continuous research has given birth to some recent developments in diabetes treatment. These new solutions could not only make managing diabetes easier, but they could also potentially help cure the disease. Here are some of the most recent developments in diabetes treatment.

Remission induced by intensive therapy

Up until recently, managing diabetes was the only course of action for people with the condition. Recent research, however, has opened up the possibility for remission. In a study consisting of 83 participants with type 2 diabetes, researchers developed an intensive treatment plan spanning across two to four months, using a combination of oral medications, lifestyle therapies, and insulin. 40% of those participants went into remission and remained diabetes-free for around 3 months. While it may seem like a fragile achievement, it’s a significant step in diabetes treatment because this study proved it was possible to actually reverse diabetes, and not simply manage it.

Islet cell transplant

Islet cells present in the pancreas are responsible for producing insulin. In patients with type 1 diabetes, these cells are destroyed by an autoimmune response in the body, leading to stoppage of insulin production. In 2016, patients with type 1 diabetes saw new hope, when insulin-producing islet cells were transplanted in omentum of a patient with the disease. The omentum is a layer of fatty tissues in the abdomen, and from this transplant, it appears to be a safer site than the liver, which was where islet transplants were traditionally done. Transplanting islet cells in the omentum has proven to be successful in this case, with the patient no longer requiring insulin injections.

More effective medicines

Type 2 diabetes is a condition wherein the body becomes resistant to insulin. As a result, blood sugar levels tend to rise. Typically, patients with type 2 diabetes start diabetes treatment with drugs like metformin, which is a Glucophage. The downside of these medicines is that while they may help tackle high levels of blood sugar, they could also lower them to dangerous levels. Fortunately, newer drugs like TTP399, when taken in combination with metformin, can help control blood sugar without causing hypoglycemia. TTP399 recently completed a 6-month phase 2 trial in patients with type 2 diabetes. If things progress in the right manner, patients could have more effective drugs for managing diabetes.

Developments in Diabetes Treatment

Source: sec.gov

Possibility of a diabetes vaccine

Clinical trials for a vaccine to prevent type 1 diabetes in children began in 2018. When the relationship between enteroviruses and diabetes was established in 2014, the possibility of a vaccine being the solution became more concrete. These viruses are extremely common in newborns, and around 25% of enterovirus infections were identified as coxsackievirus cases. It’s this virus that has been associated with diabetes. Newborns who are affected by this enterovirus could develop type 1 diabetes early in life, leading to a lifetime of struggle. However, with vaccines bringing in immunity to these viruses, the cases of type 1 diabetes in children could reduce significantly.

If these new diabetes treatments are approved and made accessible to the public, it might be the beginning of a medical revolution that has been a long time coming. And when it does get here, you’ll want to be financially prepared. A health insurance policy can help you there. On Finserv MARKETS, you can obtain health covers ranging between 1.5 lakhs to 50 lakhs. Additionally, since there are no third-party deals involved, claim settlement is also quick and hassle-free. What’s even better is that you can have your health insurance policy on Finserv MARKETS tailored to suit the specific health requirements of your family. With so many customer-centric advantages, you’ll be glad you took a health cover available on Finserv MARKETS.

Finserv MARKETS, a subsidiary of Bajaj Finserv, is a one-stop digital marketplace that has been created for consumers on the go. It offers 500+ financial and lifestyle products, all at one place. At Finserv MARKETS, we understand that every individual is different. And that’s why we have invested in creating a proposition – Offers You Value. A value proposition that ensures you get offers which are tailor made for you. We also offer an amazing product range and unique set of online offers across Loans, Insurance, Investment, Payments and an exclusive EMI store. Be it in helping you achieve your financial life goals or offering you the latest gadgets, we strive to offer what you are looking for. From simple and fast loan application processes to seamless and hassle-free claim-settlements, from no cost EMIs to 4 hours product delivery, we work towards fulfilling all your personal and financial needs. What’s more! Now enjoy the same benefits in just one click with our Finserv MARKETS App.

Comments

Connect with Us
Connect with Us

Bajaj Finserv Direct Limited ("BFDL"), erstwhile Bajaj Financial Holdings Limited is a registered corporate agent of Bajaj Allianz Life Insurance Company Limited and Bajaj Allianz General Insurance Company Limited under the IRDAI composite registration number CA0551 valid till 10-Apr-2021. BFDL also renders services to Bajaj Finance Limited (‘BFL’) and Bajaj Housing Finance Limited (‘BHFL’) (referred hereinafter as ‘Lending Partner’) in sourcing of customers, providing preliminary credit support activities, fulfilment services and post-acquisition customer services related to lending business. Registered Office: Bajaj Auto Limited Complex, Mumbai – Pune Road, Akurdi, Pune – 411 035 CIN: U65923PN2014PLC150522